Harbour Investments’s iShares Neuroscience and Healthcare ETF IBRN Stock Holding History

Harbour Investments’s Portfolio IBRN Stock Details IBRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-56	Closed	-$1.47K	–	3937
2025 Q3	$1.47K	Buy	+56	New	+$1.36K	﹤0.01%	3344

Other funds holding IBRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Harbour Investments's IBRN Position: Q4 2025 in Review

Harbour Investments sold out of iShares Neuroscience and Healthcare ETF (IBRN) in Q4 2025, closing a stake of 56 shares — an estimated $1.47K sold.

Harbour Investments first reported a position in IBRN in Q3 2025 and held it in 1 quarter. The position peaked at $1.47K in Q3 2025. 3 funds tracked by Wall St. Rank hold IBRN as of Q4 2025.

Harbour Investments reported no remaining iShares Neuroscience and Healthcare ETF position as of Q4 2025 after selling out during the quarter.
Harbour Investments sold 56 iShares Neuroscience and Healthcare ETF shares in Q4 2025, an estimated $1.47K.
Harbour Investments first reported a position in iShares Neuroscience and Healthcare ETF in Q3 2025 and held it in 1 quarter.
Harbour Investments's iShares Neuroscience and Healthcare ETF position peaked at $1.47K in Q3 2025.
3 funds tracked by Wall St. Rank held iShares Neuroscience and Healthcare ETF as of Q4 2025.

Based on Harbour Investments's 13F filing for Q4 2025, filed 9 Feb 2026.